Clinical trial
Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1)
NCT00086645 · Boston University, Other · Completed
Key facts
| NCT number | NCT00086645 |
|---|---|
| Title | Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1) |
| Official title | Citalopram Treatment in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior |
| Lead sponsor | Boston University, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Autistic Disorder |
| Intervention type | Drug, Other |
| Interventions | citalopram hydrobromide, placebo |
| Enrollment | 149 |
| Start date | Apr 1, 2004 |
| Primary completion | Oct 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Jul 13, 2004 |
| Last update posted | Mar 10, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: